Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Placebo Effects in Depressed Older Adults
NCT04836533Phase 1Withdrawn
- Sponsor
- Queens College, City University of New York
- Start
- Jan 2023
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of escitalopram in major depressive disorder (MDD), sponsored by Queens College, City University of New York. Planned start Jan 2023; status: withdrawn.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04836533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04836533.